Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

UAE Facilitates Training of Healthcare Professionals for Diabetes

Nov 02, 2010
Share |
 
The UAE has one of the highest prevalence of diabetes in the world. Various factors such as lifestyle changes, unhealthy diet, and rising elderly population have been spurring the number of diabetic patients in the country. Considering the fact that the disease state is very critical, the UAE government is running several awareness programs that may help the diabetes care market to post strong growth. The UAE health ministry has raised its concern against diabetes and has signed a co-operation agreement with the pharma major Merck Serono Middle East to address the growing quandary. Under the agreement, American Association of Clinical Endocrinologists will randomly select 200 doctors to participate in phase one of the initiative for training doctors.
 
According to our latest research report, Diabetes Market in UAE, the prevalence of diabetes has reached an alarming level and one out of every five persons in the country is suffering from the disease. With increasing prevalence of diabetes, several other associated chronic diseases like CVD have become more common and hence, increasing financial burden on the government. To counter this problem, there is an urgent need to promote diabetes care programs, which include both preventive and conclusive efforts.
 
Besides, we have done extensive research and prudent analysis of the UAE Diabetes market to understand factors that will continue to serve as growth drivers for the UAE diabetes care market during the forecast period (2010-2012). We have identified that the diabetes care market in the UAE is projected to grow at a CAGR of nearly 8.5% during 2010-2012. Moreover, growth in insulin sales in the country will be largely associated with the increase in prevalence of type I diabetes. It is anticipated that, there will be a high growth in the prevalence of type I diabetes, and this will propel the demand for insulin in the country.
 
"Diabetes Market in UAE" provides a complete overview of the UAE diabetes care market. It presents clients with critical details about the future prospects of the UAE diabetes care market, supplemented with quantitative data and rational analysis of potential demand areas. Besides, it contains critical information about key players along with their business strategies and area of expertise. This will provide clients an additional edge over their competitors while devising business plans.

For more information visit: http://www.rncos.com/Report/IM247.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports